Godrej Agrovet Ltd.'s shares fell 8% on May 2 after flat March quarter revenue, EBITDA, and margins. The stock, down 20% from its 52-week high, saw profitability rise 24% driven by crop protection and oil businesses. Subsidiary Astec Lifesciences faced challenges, while animal feed and dairy margins remained flat or declined. Analysts mostly hold "buy" ratings, with shares trading at ₹712.1.
Read more at CNBCAd
Ad